The Role of DaTscan in the Diagnosis of Dementia with Lewy bodies (DLB), episode 8 of our Community Webinar Series, examines the overlapping pathology and symptoms of Parkinson’s and Alzheimer’s diseases, which can create challenges to diagnosing Dementia with Lewy bodies (DLB). Research suggests that DLB is the most often misdiagnosed form of progressive dementia, requiring multiple visits to providers and up to 18 months to receive an accurate diagnosis.
Dr. Jennifer Goldman, Chair, LBDA Scientific Advisory Council, will explore the role of DaTscan in the diagnosis of DLB and provide an overview of the benefits and limitations of this technology in the diagnostic process.
Following this webinar, you will be able to:
1. Define DaTscan and describe how it is administered in a health care setting.
2. Describe the role of DaTscan in the diagnosis of DLB.
3. Summarize the benefits and limitations of DaTscan technology in the diagnosis of DLB.
About Dr. Jennifer Goldman, M.D., M.S.
Dr. Goldman was Section Chief of Parkinson’s and Movement Disorders at the Shirley Ryan AbilityLab (formerly the Rehabilitation Institute of Chicago) and Professor of Physical Medicine & Rehabilitation and Neurology at the Northwestern University Feinberg School of Medicine. Prior to that, she was Movement Disorders faculty at Rush University Medical Center and Professor of Neurological Sciences at Rush. Her research focus includes defining clinical features and operationalization of diagnostic criteria for dementia, mild cognitive impairment and psychosis for Lewy body disorders; identifying neurobiological mechanisms via neuroimaging biomarkers; and improving therapeutics, both pharmacological and non-pharmacological and care models; and providing and optimizing rehabilitation therapies, interdisciplinary care, and functional outcomes. Her research has been supported by the National Institutes of Health, the Michael J. Fox Foundation, the Parkinson’s Foundation, and other foundation, industry, and private sponsors. Dr. Goldman has published over 100 scholarly articles related to Lewy body disorders. She currently serves as chairperson for the Lewy Body Dementia Association Scientific Advisory Council.
This webinar is made possible by a sponsorship provided by GE HealthCare. LBDA and the presenters are solely responsible for the content in this program.